Boehringer Ingelheim· @Boehringer · X·· 2025-12-18AI 评分18
AI 导读
#NEWS：我们正在推进眼科管线。来自我们与@Numab_Tx合作、用于湿性年龄相关性黄斑变性的多特异性抗体已进入临床前开发阶段。 了解更多：https://go.boehringer.com/wiGA3 #EyeHealth #ResearchCollaboration
正文
#NEWS: We’re progressing our Eye Health pipeline. The multi-specific antibody for wet age-related macular degeneration from our collaboration with @Numab_Tx has entered preclinical development.
Learn more at https://go.boehringer.com/wiGA3
#EyeHealth #ResearchCollaboration
来源：Boehringer Ingelheim · x.com